These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


486 related items for PubMed ID: 6452660

  • 21. Screening for Down's syndrome. Data do not support study's claim.
    Norgaard-Pedersen B.
    BMJ; 2000 Sep 23; 321(7263):763; author reply 764-5. PubMed ID: 10999925
    [No Abstract] [Full Text] [Related]

  • 22. [Screening by maternal serum markers for Down's syndrome].
    Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr 23; 25(2):156-9. PubMed ID: 12905710
    [Abstract] [Full Text] [Related]

  • 23. Maternal serum markers for Down's syndrome pregnancies.
    Chew S, Anandakumar C, Ratnam SS.
    Singapore Med J; 1995 Aug 23; 36(4):417-23. PubMed ID: 8919160
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K.
    Ann Clin Biochem; 2005 Jan 23; 42(Pt 1):30-40. PubMed ID: 15802030
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Screening for Down's syndrome. Serum screening shows a clear benefit across age groups.
    McCune GS, Stock AS, Foakes A.
    BMJ; 2000 Sep 23; 321(7263):762-3; author reply 764-5. PubMed ID: 10999924
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Down's syndrome: screening and antenatal diagnosis regionally in England and Wales 1989-2008.
    De Souza E, Alberman E, Morris JK.
    J Med Screen; 2010 Sep 23; 17(4):170-5. PubMed ID: 21258126
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Using decision analysis to compare policies for antenatal screening for Down's syndrome.
    Fletcher J, Hicks NR, Kay JD, Boyd PA.
    BMJ; 1995 Aug 05; 311(7001):351-6. PubMed ID: 7640539
    [Abstract] [Full Text] [Related]

  • 40. Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register.
    Morris JK, Alberman E.
    BMJ; 2009 Oct 26; 339():b3794. PubMed ID: 19858532
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.